City: Beginning with Krypton Gold As God

,

Chapter 664, Centralized State Purchasing, Stocks Soaring (1 more, please customize)

When Carlyle Pharmaceuticals produced this drug, it had already caused a hot search on Weibo.

Many people knew the news, and it was a complete boon for everyone.

"Carlyle Medicine is really amazing. It has really researched this drug, and the drug has a very strong effect and has long-term effects in the Phase III clinical study."

"My grandfather had Alzheimer's disease some time ago, and the symptoms are getting more and more serious now. After this drug comes out, it can be treated, but the cost of this drug is really expensive."

"Yeah, I think the price prescribed by the hospital before was about 12 to 15."

"This drug must be because the research and development costs of others have not been included. If all the treatment is carried out at a very low price, then there is no money to continue research and development.

So I think this fee is definitely higher in the early stage, but with the addition of medical insurance in the later stage, the price should be much cheaper."

In fact, most people in China do not have the awareness of buying this kind of commercial insurance, and if they do, it is only a part of the people.

However, some people still buy this commercial insurance, which means that if they encounter this kind of Alzheimer's disease treatment, they can be reimbursed.

Probably...how much the hospital charges, then how much is reimbursed.

You may need to pay a little less money yourself.

Ye Fan is also paying attention to this topic on Weibo after their drug was launched.

Sure enough, many people are discussing on Weibo, of course, the most discussed is... about the price of this drug, and the question of the efficacy of this drug.

The problem of drug efficacy does not need to be said, because it has been proved from clinical practice that the cure rate reaches 100%.

Coupled with this drug, other side effects are very small, and according to the results of the Phase III clinical trial, it did not cause any side effects.

If there is, it is a slight phenomenon that may be a little vomiting, but this is probably ... ... a reaction to a person who has such a reaction.

Most of these other patients who participated ended up not having such a response.

Therefore, it is not necessary to say more about the efficacy of this drug. You will know how effective it is after treatment. But Ye Fan is most concerned about the price. At present, according to the pricing, the price of this treatment in the hospital should be Between 12 and 15.

So for ordinary people, this price is indeed very expensive.

But at present, Ye Fan himself has no way to lower this to him.

Because he also wants to make money, after all, Ye Fan does not want Lei Capital to transfuse blood in the follow-up research and development.

I have already given this money and this technology, and of course I hope that independent development can be carried out, and then it must involve a profit issue.

The topic on this network was immediately hyped, and it went directly to the top of the entire hot search, which obviously alarmed the entire senior management.

Basically, what is reflected on Weibo should be people's livelihood issues, so the management department above also attaches great importance to it.

Because people have such needs, they also like to say that the treatment of this disease can be included in social security.

I hope that medical insurance can be used for reimbursement, otherwise many people actually look down on this disease.

This matter has not passed for a day, and then Keller Pharmaceuticals probably received news from the management department, and they will probably have this kind of negotiation with them.

At present, according to the results of the survey, there are approximately more than 200 million cases of Alzheimer's disease in China.

If all these cases are treated, the total amount is probably more than 200 billion.

That is to say, if 70% of medical insurance is reimbursed, there will be more than 140 billion yuan.

Even if the medical insurance company is rich, the number of words is indeed very large.

Therefore, it is necessary to negotiate with Carlyle Medicine, that is, to reduce the price of drugs, and then to conduct centralized procurement.

"Mr. Ye, we have received a call from the management department. They asked if we could lower the price on the basis of 10. They want to make centralized purchases."

Zhou Kai called Ye Fan just to tell him his opinion about the current management department.

"Yes, if all domestic pharmaceutical companies are purchasing, our drug can be negotiated.

Otherwise, the drug we produced was originally intended to act on patients with this disease.

But there is one point, we must guarantee our profit, I think the lowest price should not be lower than 6."

Originally, after their drug was developed, the profit was about 9 times, but now Ye Fan is reducing it, and it will only be about 5 times the profit in the end, it depends on whether the management department is willing or not.

This is very good, it can guarantee all production and sales, and you don't need to do marketing yourself, and the country has the bottom line.

"Understood Mr. Ye, we will negotiate with them, which is probably our lowest bottom line."

Zhou Kai himself went to this arrangement immediately, since it was what Ye Fan said, he had to do it according to his requirements.

And he still doesn't know what the outcome of this kind of negotiation will be, but he has to do it.

It should be known that the number of people suffering from Alzheimer's disease in the world has reached as high as: nearly 500 million people, so the treatment of this disease can bring them more lucrative income.

And as the population gets older, the number of patients with this disease increases almost every year.

The result of the negotiation came out in about a day, and the final price was set at 7.

Originally they set a price of 10 yuan, but now it has been reduced to 7 yuan.

Medical insurance can cover more than 70% of the reimbursement, which is probably close to 5 yuan: reimbursement.

That is to say, the proportion of individuals who said they would invest is about 2 yuan.